Acute leukemia in children: experience in Saskatchewan in 1966-72.
In 1966-72 in Saskatchewan there was a significant improvement in survival of patients up to 16 years old with acute leukemia treated intensively.  The rate of complications was low.  Attention to the emotional needs of the patients and parents and formation of parent mutual-support groups improved the acceptibility of intensive therapy.
D000208:Acute Disease; D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001803:Blood Transfusion; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006412:Hematopoietic Stem Cells; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000628:therapy; D010166:Palliative Care; D011241:Prednisone / Q000627:therapeutic use; D012525:Saskatchewan; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone; D003630:Daunorubicin